Immunotherapy-naive

Clinical trials for Immunotherapy-naive explained in plain language.

Never miss a new study

Get alerted when new Immunotherapy-naive trials appear

Sign up with your email to follow new studies for Immunotherapy-naive, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New combo therapy targets hard-to-treat pancreatic cancer liver spread

Disease control Not yet recruiting

This study tests a new first-line treatment for people with pancreatic cancer that has spread to the liver. The treatment combines chemotherapy delivered directly to the liver with two immunotherapy drugs. The goal is to see if this approach can slow or stop cancer growth. The st…

Matched conditions: IMMUNOTHERAPY-NAIVE

Phase 2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:10 UTC

Immunotherapy-naive

Get alerted when new Immunotherapy-naive trials appear

New combo therapy targets hard-to-treat pancreatic cancer liver spread